AKT1 and neoplasm: According to the same study, TVB-3664 treatment has been associated with a decrease in the tumor size in 30% of cases, with reduction in FFAs and phospholipids synthesis and with alteration of AMPK, Akt, and Erk1/2 oncogenic axis [120].